Ertapenem Injection
Ertapenem injection is a carbapenem antibiotic used to treat moderate to severe bacterial infections including abdominal, skin, urinary tract, lung, and pelvic infections, and to prevent surgical site infection after colorectal surgery.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 17 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Ertapenem Injection: Patient Information Guide
A plain-language walkthrough of Ertapenem Injection — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Ertapenem injection is a carbapenem antibiotic approved for treating and, in one specific situation, preventing serious bacterial infections. The following uses are supported across the evidence:
- Complicated intra-abdominal (abdominal cavity) infections — in adults and children 3 months and older
- Complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis (bone infection) — in adults and children 3 months and older
- Community-acquired pneumonia — in adults and children 3 months and older
- Complicated urinary tract infections, including pyelonephritis (kidney infection) — in adults and children 3 months and older
- Acute pelvic infections, including postpartum endomyometritis (uterine lining infection after delivery), septic abortion, and post-surgical gynecologic infections — in adults and children 3 months and older
- In adults only: prevention of surgical site infection following elective colorectal surgery (single IV dose before the procedure)
⚙️How it works▾
Ertapenem is a carbapenem antibiotic that kills bacteria by blocking the construction of their cell walls. Bacteria need a sturdy cell wall to hold their shape and protect themselves — without it, they fall apart and die. Because human cells do not have cell walls, this mechanism targets the bacteria specifically.
It is important to use ertapenem only for infections caused by bacteria that are actually susceptible to it. Overuse or inappropriate use of antibiotics can lead to drug-resistant bacteria — germs that no longer respond to treatment — making future infections harder to treat.
💊How it's taken▾
Ertapenem injection is given either as a slow IV infusion into a vein (over 30 minutes) or as an IM injection into a large muscle. Adults and teenagers 13 and older typically receive one dose daily; children 3 months to 12 years typically receive doses twice daily. The surgical prevention dose for adults is a single IV infusion given 1 hour before the operation.
- IV treatment may continue for up to 14 days; IM treatment for up to 7 days.
- Adults with significant kidney impairment or those on hemodialysis may need a lower or adjusted dose — your prescriber will determine this.
- There is no specific dose adjustment guidance for liver impairment.
- Always follow your prescriber's exact schedule; do not skip doses or stop early without medical guidance.
🤒Side effects — in detail▾
Most side effects with ertapenem are mild to moderate. The most commonly reported include:
- Diarrhea
- Nausea and vomiting
- Headache
- Infusion or injection site pain, redness, or swelling
- Altered mental status or confusion
- Constipation
- Rash
- Fever
More serious reactions — including severe allergic reactions (anaphylaxis), seizures, and Clostridioides difficile (C. diff) diarrhea that can range from mild to life-threatening — require immediate medical attention. If you develop difficulty breathing, hives, seizures, or severe diarrhea, contact your healthcare provider or seek emergency care right away.
⚠️Warnings & precautions▾
- Severe allergic reactions (anaphylaxis): Potentially life-threatening reactions have occurred with ertapenem and other beta-lactam antibiotics. People with a history of penicillin or beta-lactam allergy are at higher risk. Emergency treatment is required if a reaction occurs.
- Seizures: Seizures and other nervous system effects have been reported, most commonly in people with existing brain conditions or reduced kidney function. Tell your doctor if you have a history of seizures.
- Valproic acid interaction: Ertapenem can sharply reduce blood levels of valproic acid or divalproex sodium (seizure medications), potentially triggering a breakthrough seizure. This combination is generally not recommended.
- C. difficile diarrhea (CDAD): Like all antibiotics, ertapenem can disrupt normal gut bacteria and allow C. difficile to overgrow, causing diarrhea that can become severe or fatal. This can occur even weeks after finishing the antibiotic.
- IM injection precaution: When given as an intramuscular injection, care must be taken to avoid injecting into a blood vessel. The IM solution contains lidocaine and must never be injected into a vein.
- Drug resistance: Ertapenem should only be used for proven or strongly suspected bacterial infections to help preserve antibiotic effectiveness.
🔀What it interacts with▾
Ertapenem has two key drug interactions to be aware of:
- Valproic acid / divalproex sodium: Ertapenem significantly lowers blood levels of these seizure medications. This can cause breakthrough seizures even in people whose epilepsy has been stable. This combination is generally avoided; a different antibiotic should be chosen if possible.
- Probenecid: This gout medication blocks the kidneys from clearing ertapenem normally, causing ertapenem levels in the blood to rise. These two drugs should not be taken together.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your doctor about any allergy to penicillin, cephalosporins, or other beta-lactam antibiotics — cross-reactions can occur.
- Tell your doctor if you are allergic to amide-type local anesthetics (such as lidocaine or bupivacaine) — the intramuscular form is prepared with lidocaine and is contraindicated if you have this allergy.
- Tell your doctor if you have a history of seizures, brain lesions, or other central nervous system disorders.
- Tell your doctor if you have kidney disease — dose adjustments are needed for significant kidney impairment, and hemodialysis patients require special dosing.
- Tell your doctor if you take valproic acid or divalproex sodium for seizure control — ertapenem can lower their levels dangerously.
- If you are pregnant or may become pregnant, discuss the risks and benefits with your doctor. Limited human data exist; animal studies did not show major birth defects at clinically relevant doses.
- Ertapenem passes into breast milk in small amounts. Discuss breastfeeding with your doctor, weighing your need for the medication against any potential risk to the infant.
- Ertapenem is approved for children as young as 3 months, but there is no dosing data for children with kidney disease or those on dialysis.
🚑If you take too much▾
Taking too much ertapenem may cause nausea, diarrhea, and dizziness. If an overdose is suspected, ertapenem should be stopped and supportive care given while the kidneys clear the drug from the body.
Ertapenem can be partially removed by hemodialysis, though there is no established protocol specifically for treating overdose with dialysis. Seek medical attention immediately if an overdose is suspected.
🔬Pharmacokinetics — how your body processes it▾
When ertapenem is given by IV infusion, it reaches high blood levels quickly. When given as an IM injection, it is almost completely absorbed — about 90% of the dose reaches the bloodstream — with peak levels occurring roughly 2.3 hours after injection. It binds strongly to proteins in the blood, primarily albumin, with the degree of binding decreasing as drug levels rise.
Ertapenem does not build up in the body with daily dosing. It is cleared primarily by the kidneys, so people with significant kidney impairment clear it more slowly and may need a reduced dose. The drug can be partially removed by hemodialysis.
📦How to store it▾
store lyophilized powder above 25°C (77°F). stored at room temperature (25°C) and used within 6 hours or stored for 24 hours under refrigeration (5°C) and used within 4 hours after removal from refrigeration.
📄 Written from Ertapenem Injection’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Ertapenem Injection
50 supplements and herbal products have documented interactions with Ertapenem Injection in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 39
- Minor · 10
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Ertapenem Injection has been associated with lower levels of 7 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 6
- Moderate · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Ertapenem Injection — the kind of thing our pharmacy team would talk through with you at the counter.
What kinds of infections does ertapenem treat? ▾
How will I receive this medication — is it a pill? ▾
What side effects should I expect, and which ones should I call about? ▾
I take valproic acid for my epilepsy. Is ertapenem safe for me? ▾
Is it safe to use during pregnancy or while breastfeeding? ▾
Do I need a lower dose if I have kidney problems? ▾
Is Ertapenem Injection available over the counter? ▾
When was Ertapenem Injection first available? ▾
Who makes Ertapenem Injection? ▾
💬 Answers drafted from Ertapenem Injection’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Ertapenem Injection comes
Ertapenem Injection is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Invanz is used intravenously or intramuscularly to treat complicated abdominal, skin, urinary tract, lung, and pelvic infections in adults and children 3 months and older.
- Invanz given intravenously is used in adults to prevent surgical site infection following elective colorectal surgery.
- Invanz intramuscular injection may be used as an alternative to IV treatment for appropriate infections.
- Invanz is used only against infections proven or strongly suspected to be caused by susceptible bacteria.
- Invanz given by IV is infused over 30 minutes; IV treatment may continue for up to 14 days.
- Invanz given by IM injection is administered deep into a large muscle and may be used for up to 7 days — the IM solution is prepared with lidocaine and must never be given intravenously.
- Invanz must not be mixed or co-infused with other medications, and diluents containing dextrose must not be used.
- Invanz dosing may need adjustment in adults with significant kidney impairment or those on hemodialysis — follow your prescriber's instructions closely.
📊 Ertapenem Injection across the U.S. market
How Ertapenem Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Ertapenem Injection is used
A general measure of how commonly Ertapenem Injection is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Ertapenem Injection is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Ertapenem Injection prescribed? Of the 1,596 medications we measure, Ertapenem Injection ranks #580 by Medicaid prescriptions — more than 64% of them.
Utilization by Ertapenem Injection product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
ertapenem 1000 MG Injection
Summed across the 17 of 36 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1734683
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Ertapenem Injection, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 17 of 36 listed Ertapenem Injection NDCs with Medicaid activity.
🔍 Compare Ertapenem Injection products
A representative set of FDA-listed product records for Ertapenem Injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 1 g/20 mL | Intramuscular, Intravenous | Apotex Corp | ANDA | View NDC → |
| 1 g/20 mL | Intramuscular; Intravenous | Apotex Corp | ANDA | View NDC → |
| 1 g | Intramuscular; Intravenous | AuroMedics Pharma LLC × 2 listings | ANDA | View NDC → |
| 1 g/20 mL | Intramuscular, Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 1 g/20 mL | Intramuscular; Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 1 g | Intramuscular; Intravenous | Dr.Reddy | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Dr.Reddys Laboratories Inc., | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | ENDO USA, Inc. × 2 listings | NDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 1 g | Intramuscular; Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Fosun Pharma USA Inc | ANDA | View NDC → |
| 1 g | Intramuscular; Intravenous | Fosun Pharma USA Inc | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Hikma Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 1 g | Intramuscular; Intravenous | Hikma Pharmaceuticals USA, Inc. × 2 listings | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 1 g | Intramuscular; Intravenous | Hospira, Inc. × 2 listings | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Merck Sharp & Dohme LLC | NDA | View NDC → |
| 1 g | Intramuscular; Intravenous | Merck Sharp & Dohme LLC | NDA | View NDC → |
| 1 g | Intramuscular, Intravenous | NorthStar RxLLC | ANDA | View NDC → |
| 1 g | Intramuscular; Intravenous | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 1 g | Intramuscular; Intravenous | Par Pharmaceutical Inc. × 3 listings | NDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Qilu Antibiotics Pharmaceutical Co., Ltd. | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | Sagent Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 1 g/20 mL | Intramuscular, Intravenous | Savior Lifetec Corporation | ANDA | View NDC → |
| 1 g/20 mL | Intramuscular; Intravenous | Savior Lifetec Corporation | ANDA | View NDC → |
| 1 g | Intramuscular, Intravenous | WG Critical Care, LLC | ANDA | View NDC → |
Showing 39 of 39 products — FDA National Drug Code Directory. See every product, package size and price: browse all 39 Ertapenem Injection NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ertapenem Injection — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ertapenem Injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Ertapenem Injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 325642 1 dose form · 1 strength
-
Dose form (SCDF) Injection RxCUI 1734682In current FDA listingsClinical drug / strength (SCD) 1000 MGRxCUI 1734683
Look up RxCUI 325642 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Ertapenem Injection is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Ertapenem Injection belongs to the Penem Antibacterial class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 17 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Merck Sharp & Dohme LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.